首页> 外文期刊>Medicinal chemistry >Bioisosteric Replacement and Related Analogs in the Design, Synthesis and Evaluation of Ligands for Muscarinic Acetylcholine Receptors
【24h】

Bioisosteric Replacement and Related Analogs in the Design, Synthesis and Evaluation of Ligands for Muscarinic Acetylcholine Receptors

机译:毒蕈碱型乙酰胆碱受体配体的设计,合成和评估中的生物等位取代和相关类似物

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Previous structure-activity relationship studies involving a series of lactone-based muscarinic ligands identified a lead compound containing a diphenylmethylpiperazine moiety (4; IC50 = 340 nM). The purpose of the present work is to investigate 1,3-benzodioxoles, 4,4-diethyl substituted tetrahydrofurans, 5-substituted oxazolidinones and chromones as bioisosteric replacements for the lactone ring in a novel series of muscarinic ligands. The approach provided compounds with improved % inhibition values and identified a non-selective muscarinic ligand with an IC50 value of 280 nM. The structure-activity relationship for this new series will be discussed. Selected compounds were evaluated in preliminary assays for subtype selectivity and were found to be non-selective.
机译:以前的涉及一系列基于内酯的毒蕈碱配体的结构活性关系研究确定了一种含二苯基甲基哌嗪部分的铅化合物(4; IC50 = 340 nM)。本工作的目的是研究1,3-苯并二恶唑,4,4-二乙基取代的四氢呋喃,5-取代的恶唑烷酮和色酮作为新型毒蕈碱配体中内酯环的生物等位替代物。该方法为化合物提供了更高的%抑制值,并鉴定出IC50值为280 nM的非选择性毒蕈碱配体。将讨论这个新系列的构效关系。在初步测定中评估了所选化合物的亚型选择性,发现它们是非选择性的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号